These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3778483)

  • 1. CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells.
    Roberts JJ; Friedlos F; Knox RJ
    Biochem Biophys Res Commun; 1986 Nov; 140(3):1073-8. PubMed ID: 3778483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells.
    Knox RJ; Friedlos F; Jarman M; Roberts JJ
    Biochem Pharmacol; 1988 Dec; 37(24):4661-9. PubMed ID: 3202902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of ribonucleotide reductase by the monofunctional alkylating agent 5(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954).
    Tisdale MJ; Habberfield AD
    Biochem Pharmacol; 1980 Oct; 29(20):2845-53. PubMed ID: 7002161
    [No Abstract]   [Full Text] [Related]  

  • 4. Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in Walker cells.
    Roberts JJ; Marchbank T; Kotsaki-Kovatsi VP; Boland MP; Friedlos F; Knox RJ
    Biochem Pharmacol; 1989 Nov; 38(22):4137-43. PubMed ID: 2480794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of the anti-tumour agent 1(1-aziridinyl)- 2,4-dinitrobenzene (CB 1837).
    Connors TA; Hickman JA; Jarman M; Melzack DH; Ross WC
    Biochem Pharmacol; 1975 Sep; 24(18):1665-70. PubMed ID: 1191326
    [No Abstract]   [Full Text] [Related]  

  • 6. The Walker 256 carcinoma: a cell type inherently sensitive only to those difunctional agents that can form DNA interstrand crosslinks.
    Knox RJ; Lydall DA; Friedlos F; Basham C; Rawlings CJ; Roberts JJ
    Mutat Res; 1991 Nov; 255(3):227-40. PubMed ID: 1719394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The properties of total adducts and interstrand crosslinks in the DNA of cells treated with CB 1954. Exceptional frequency and stability of the crosslink.
    Friedlos F; Quinn J; Knox RJ; Roberts JJ
    Biochem Pharmacol; 1992 Mar; 43(6):1249-54. PubMed ID: 1562278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of the anti-tumour agent 5-(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954).
    Jarman M; Melzack DH; Ross WC
    Biochem Pharmacol; 1976 Nov; 25(22):2475-8. PubMed ID: 985569
    [No Abstract]   [Full Text] [Related]  

  • 9. The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2).
    Knox RJ; Boland MP; Friedlos F; Coles B; Southan C; Roberts JJ
    Biochem Pharmacol; 1988 Dec; 37(24):4671-7. PubMed ID: 3144286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization by the 2,4-dinitro-5-aziridinyl benzamide CB 1954: a structure/activity study.
    Walling JM; Stratford IJ; Adams GE
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):31-41. PubMed ID: 3496308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The toxicity and mutagenicity of the anti-tumour drug 5-aziridino-2,4-dinitrobenzamide (CB1954) is greatly reduced in a nitroreductase-deficient strain of E. coli.
    Venitt S; Crofton-Sleigh C
    Mutagenesis; 1987 Sep; 2(5):375-81. PubMed ID: 3325769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB 1954: from the Walker tumor to NQO2 and VDEPT.
    Knox RJ; Burke PJ; Chen S; Kerr DJ
    Curr Pharm Des; 2003; 9(26):2091-104. PubMed ID: 14529407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the Walker tumour.
    Connors TA; Melzack DH
    Int J Cancer; 1971 Jan; 7(1):86-92. PubMed ID: 5546147
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA alkylation and formation of DNA interstrand cross-links by potential antitumour 2,5-bis(1-aziridinyl)-1,4-benzoquinones.
    Lusthof KJ; De Mol NJ; Janssen LH; Verboom W; Reinhoudt DN
    Chem Biol Interact; 1989; 70(3-4):249-62. PubMed ID: 2663197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, synthesis and properties of 5-(aziridin-1-yl)-2-nitro-4-nitrosobenzamide, a novel DNA crosslinking agent derived from CB1954.
    Knox RJ; Friedlos F; Biggs PJ; Flitter WD; Gaskell M; Goddard P; Davies L; Jarman M
    Biochem Pharmacol; 1993 Sep; 46(5):797-803. PubMed ID: 8373433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT).
    Knox RJ; Friedlos F; Boland MP
    Cancer Metastasis Rev; 1993 Jun; 12(2):195-212. PubMed ID: 8375021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitizing and cytotoxicity studies with CB 1954 (2,4-dinitro-5-aziridinylbenzamide).
    Stratford IJ; Williamson C; Hoe S; Adams GE
    Radiat Res; 1981 Dec; 88(3):502-9. PubMed ID: 7313077
    [No Abstract]   [Full Text] [Related]  

  • 18. The alkylation of DNA in vitro by 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinyl-1,4-benzoquinone (BZQ)--I.
    Butler J; Hoey BM; Ward TH
    Biochem Pharmacol; 1989 Mar; 38(6):923-7. PubMed ID: 2930592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lack of correlation between toxicity and free radical formation of two diaziridinyl benzoquinones.
    Lea JS; Garner HJ; Butler J; Hoey BM; Ward TH
    Biochem Pharmacol; 1988 May; 37(10):2023-5. PubMed ID: 2837220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different type of DNA damage caused by three aziridinyl substituted cyclophosphazenes in a human small cell lung carcinoma cell line.
    Zijlstra JG; de Jong S; van de Grampel JC; de Vries EG; Mulder NH
    Cancer Res; 1986 Jun; 46(6):2726-9. PubMed ID: 3008999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.